Overview

Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate treatment with Leukostim (Filgrastim; granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
Clinical Institute of the Brain, Russia
Collaborators:
City Hospital No 40, Saint Petersburg, Russia
Institute of Medical Cells Technologies
Treatments:
Lenograstim